TSS
CNCE

Two Sigma Securities’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Two Sigma Securities’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,921
Closed -$34K – 2660
2021
Q4 		$34K Buy
+10,921
New +$36.3K ﹤0.01% 1338

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Two Sigma Securities's CNCE Position: Q1 2022 in Review

Two Sigma Securities sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2022, closing a stake of 10,921 shares — an estimated $34K sold.

Two Sigma Securities first reported a position in CNCE in Q4 2021 and held it in 1 quarter. The position peaked at $34K in Q4 2021. 53 funds tracked by Wall St. Rank hold CNCE as of Q1 2022.

  • Two Sigma Securities reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Securities sold 10,921 Concert Pharmaceuticals, Inc. shares in Q1 2022, an estimated $34K.
  • Two Sigma Securities first reported a position in Concert Pharmaceuticals, Inc. in Q4 2021 and held it in 1 quarter.
  • Two Sigma Securities's Concert Pharmaceuticals, Inc. position peaked at $34K in Q4 2021.
  • 53 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2022.

Based on Two Sigma Securities's 13F filing for Q1 2022, filed 16 May 2022.